George S. Mack is founder and managing director of BioDecade where he is in an analyst and writer focusing on the field of molecular biology. Clientele include institutional investors, venture capitalists, intellectual property lawyers and C-level executives in the biotechnology and pharmaceutical industries.
Dr. Mack is a consulting analyst for Decision Resources where he produces pharma and biotech industry reports, and he is a feature writer at Nature Biotechnology which ranks first out of the 132 journals in the category of biotechnology and applied microbiology and is among the top 20 scientific journals in the world according to the ISI citation journal reports. Media outlets in the past decade include Wall Street Research, Reuters Research, Journal of the National Cancer Institute, MSN Money on CNBC and Nature Medicine. He is a regular guest and commentator on South Carolina's statewide network of National Public Radio affiliates.
He is a graduate of the University of South Carolina in Columbia where he earned his BS and majored in biology and the Medical University of South Carolina in Charleston where he earned his DMD degree.